12/5
08:38 am
dnli
Rating for DNLI
Report
Rating for DNLI
12/5
08:38 am
dnli
Rating for DNLI
Report
Rating for DNLI
12/5
08:09 am
dnli
Denali Therapeutics (NASDAQ:DNLI) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $32.00 price target on the stock.
Report
Denali Therapeutics (NASDAQ:DNLI) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $32.00 price target on the stock.
12/5
08:08 am
dnli
Denali Therapeutics (NASDAQ:DNLI) had its "outperform" rating reaffirmed by analysts at Wedbush.
Report
Denali Therapeutics (NASDAQ:DNLI) had its "outperform" rating reaffirmed by analysts at Wedbush.
12/5
08:08 am
dnli
Denali Therapeutics (NASDAQ:DNLI) had its "outperform" rating reaffirmed by analysts at Wedbush.
Report
Denali Therapeutics (NASDAQ:DNLI) had its "outperform" rating reaffirmed by analysts at Wedbush.
12/5
05:35 am
dnli
Rating for DNLI
Low
Report
Rating for DNLI
11/4
09:59 am
dnli
Rating for DNLI
Low
Report
Rating for DNLI
9/8
09:58 am
dnli
Denali Therapeutics (NASDAQ:DNLI) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.
Low
Report
Denali Therapeutics (NASDAQ:DNLI) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.
9/8
09:18 am
dnli
Rating for DNLI
Low
Report
Rating for DNLI